E-Prescribing Will Diminish Importance Of Drug Marketing, PCMA Says
The advent of electronic prescribing will diminish the importance of pharmaceutical companies' marketing efforts, Pharmaceutical Care Management Association President Mark Merritt said
You may also be interested in...
The Centers for Medicare & Medicaid Services will issue a proposed rule to create partial exemption from anti-kickback laws for e-prescribing incentives
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials